Onyx Pharmaceutical Shares Undervalued With Approved Blockbuster Drugs

News | 22 February 2013

In 2012, shares of Onyx Pharmaceuticals (ONXX) shot up over 100% after several drugs became FDA approved. The company eventually settled with gains of 70% for 2012. However, shares are now trading in the mid-range of their 52-week prices and ...

Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)